Literature DB >> 23931968

Regional differences in the utilisation of coronary angiography as initial investigation for the evaluation of patients with suspected coronary artery disease.

István Kósa1, Attila Nemes, Eva Belicza, Ferenc Király, István Vassányi.   

Abstract

Entities:  

Keywords:  Administrative databases; Coronary angiography; Coronary artery disease; Frequency; Mortality

Mesh：

Year:  2013        PMID： 23931968     DOI： 10.1016/j.ijcard.2013.07.148

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

1.  Regional variation in coronary angiography rates: the association with supply factors and the role of indication: a spatial analysis.

Authors:  Julia Frank-Tewaag; Julian Bleek; Christian Günster; Udo Schneider; Dirk Horenkamp-Sonntag; Ursula Marschall; Sebastian Franke; Kathrin Schlößler; Norbert Donner-Banzhoff; Leonie Sundmacher
Journal:  BMC Cardiovasc Disord       Date:  2022-02-26       Impact factor: 2.298

2.  The impact of geographical distances to coronary angiography laboratories on the patient evaluation pathways in patients with suspected coronary artery disease. Results from a population-based study in Hungary.

Authors:  Attila Nemes; Ferenc Király; István Vassányi; István Kósa
Journal:  Postepy Kardiol Interwencyjnej       Date:  2014-11-17       Impact factor: 1.426

3.  Correlation Clustering of Stable Angina Clinical Care Patterns for 506 Thousand Patients.

Authors:  Zsolt Vassy; István Kósa; István Vassányi
Journal:  J Healthc Eng       Date:  2017-11-14       Impact factor: 2.682

4.  Healthcare Utilization and All-Cause Premature Mortality in Hungarian Segregated Roma Settlements: Evaluation of Specific Indicators in a Cross-Sectional Study.

Authors:  János Sándor; Anita Pálinkás; Ferenc Vincze; Nóra Kovács; Valéria Sipos; László Kőrösi; Zsófia Falusi; László Pál; Gergely Fürjes; Magor Papp; Róza Ádány
Journal:  Int J Environ Res Public Health       Date:  2018-08-24       Impact factor: 3.390
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.